James W Goldfarb1, Nathaniel Reichek1, Jie J Cao1, and Dana C Peters2
1St Francis Hospital, Roslyn, NY, United States, 2Yale University, New Haven, CT, United States
Synopsis
In this proof-of-concept study, we studied the effects of a
contrast agent on R2*/T2* relaxation in dense myocardial fibrosis. A significant change in myocardial R2* was found
after contrast and an R2* difference existed after contrast agent
administration between fibrosis and remote myocardium. On average, viable
myocardial R2* increased by 4.5 Hz while infarcted increased by 9.3 Hz at 1.5T
with a clinical contrast agent.
Purpose:
The effect of gadolinium based
contrast agents (GBCA) on the T1 relaxation time in fibrosis has been well
studied with inversion recovery and T1 mapping techniques. The purpose of this
study was to assess the effects of GBCAs on viable and infarcted myocardial R2*
relaxation rates.Methods
Twenty-nine subjects with known
chronic myocardial infarction (26 men; age, 62.8±10.0 years) were studied at
1.5T with R2* mapping as well as conventional CINE and late
gadolinium-enhancement (LGE) imaging. Myocardial infarct age was 12.1±8.6 years. Additionally, seventeen healthy subjects (10
men; age, 60.8±9.0 years) were imaged with pre-contrast R2* mapping. R2*
mapping was performed using a dark blood double inversion recovery multiple
spoiled gradient-echo sequence (TR = 20 ms; 12 echo times: 2.4 - 15.5 ms, flip
angle = 20 degrees, 2.3 x 1.7 x 8 mm3) [1]. A joint water-fat
separation reconstruction [2] was performed yielding water, fat, B0 and R2*
images. The technique provides high resolution pixel R2* maps corrected for the
effects of macroscopic magnetic field variations. Both pre- and post-contrast
R2* mapping were performed in long and short-axis views. Post-contrast R2*
mapping was performed 5-10 minutes after bolus contrast agent administration
(0.15 mmol/kg gadopentetate dimeglumine) and LGE at 15 minutes after injection.
Region-of-interests (ROIs) were drawn in hyper-enhanced (infarcted) and remote
(viable) myocardium based on LGE imaging. Mean R2* as well as ROI anatomical
locations were recorded to study location bias. In normal control subjects,
ROIs were drawn in four segments of a mid-short-axis image to determine normal
values and further evaluate possible anatomical location bias. ANOVA and paired
statistical tests were used to determine the effect of the contrast agent and
fibrosis on the measured R2* relaxation rate. ANOVA was used to determine if
there was a bias due to anatomical location.Results:
There were 14 inferior, 5 lateral, 6 anterior and 4 septal
myocardial infarctions. There was no significant association of pre-contrast
R2* with anatomical location in normal or chronic MI patients (p=0.148).
Ejection fraction was lower in the MI subjects when compared to the normal
controls: 42.0 %±9.1 vs 56.9 %±5.5 (p<0.001) and LV mass was larger: 71.1
(g/m2) ±10.9 vs 56.5 ±12.7 (p<0.001). Before contrast agent administration,
the R2*’s of infarcted and remote viable myocardium were not statistically
different from each other or the normal controls (Figure 2, Table 1). After
contrast agent injection, there was a significant increase of both infarcted
and remote myocardial R2* relaxation rates (p<0.001). Additionally, the
relaxation rate of infarcted myocardium showed a greater increase compared to
viable myocardium in the same subject. An example is shown in Figure 1. On
average after contrast agent administration, viable myocardial R2* increased by
4.5 Hz and infarcted myocardial R2* by 9.3 Hz (Figure 2 and Table 1).
Discussion:
Detection of myocardial fibrosis
using the LGE technique is visualized based on a relative T1 relaxation
difference between fibrotic and normal myocardium resulting from an extracellular
volume expansion and an increased concentration of GBCA. We hypothesized that
this contrast agent difference between viable and infarcted myocardium would
also create a measurable R2*/T2* relaxation difference, for the same reasons.
R2* mapping has matured through research on iron overload and fat/water
separation [2] into a practical method, with many reports of R2* measurement
without contrast agents. Although normal values of R2*/T2* vary [3], our
pre-contrast values of about 30ms for T2* of normal, remote and infarcted
myocardium agree with these prior reports. However, we are unaware of a report
showing reference values for post-contrast R2* in normal and fibrotic tissue.
This proof-of-concept study shows that not only R1, but R2* and presumably R2
have the potential to be used to obtain post-contrast image contrast differences
in fibrotic myocardial disease. However, the T2* difference is small, i.e. 27ms
for post-contrast infarcted regions, and 24 ms for post-contrast remote
regions. This corresponds to a 1% signal difference for a TE=2ms, although the
difference could be greater in an optimized protocol. The results of this study
provide reference values to determine
the implications of R2*/T2* changes for emerging MR relaxation parameter
mapping, image synthesis and MR fingerprinting methods.Conclusion
Similar to T1 relaxation, R2*
relaxation rates change significantly with conventional contrast agent doses.
The relative greater GBCA concentration due to an increased extracellular
volume in myocardial infarction yields a faster R2* relaxation rate in fibrosis
relative to neighboring viable myocardium.Acknowledgements
No acknowledgement found.References
1. He T, Gatehouse PD, Kirk P, Tanner MA, Smith GC, Keegan J, Mohiaddin RH, Pennell DJ, Firmin DN. Black-blood T2* technique for myocardial iron measurement in thalassemia. J Magn Reson Imaging 2007;25(6):1205-1209.
2. Hernando D, Kellman P, Haldar JP, Liang ZP. Robust water/fat separation in the presence of large field inhomogeneities using a graph cut algorithm. Magn Reson Med 2010;63(1):79-90.
3. Kawel-Boehm N, Maceira A, Valsangiacomo-Buechel ER, Vogel-Claussen J, Turkbey EB, Williams R, Plein S, Tee M, Eng J, Bluemke DA. Normal values for cardiovascular magnetic resonance in adults and children. J Cardiovasc Magn Reson 2015;17:29.